Table 25 Olanzapine for children and adolescents with OSFED/EDNOS
From: Canadian practice guidelines for the treatment of children and adolescents with eating disorders
| Certainty assessment | Impact | Certainty | Importance | ||||||
|---|---|---|---|---|---|---|---|---|---|
| № of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | |||
| Global improvement (assessed with: Clinical Global Impressions Scale) | |||||||||
| 1 | Case Report | very serious a | not serious | serious b | not serious | none | Single case report of 12 year old female with EDNOS. CGI improved with olanzapine 10 mg daily. | ⨁◯◯◯ VERY LOW | IMPORTANT |